Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001302

Drug Information
NameSalmon Calcitonin
Synonymssalmon calcitonin (1-32); EINECS 256-342-8; Staporos; Oseototal; Stalcin; synthetic salmon calcitonin; Porostenina; Calcitonina; Miacalcin (TN); Salmon calcitonin-(I-32); LS-48624; Miacalcic; Kalsimin; Biocalcin; Calcitonin salmon; TZ-CT; Ipocalcin; Miracalcic; Eptacalcin; Karil; Rulicalcin; Calcitonin salmon (USAN/INN); Calcitonin (salmon); C06865; Fortical (TN); Calogen; Isi-calcin; D00249; Salcat; Osteobion; Prontocalcin; Ostostabil; Calco; 47931-85-1; C145H239N43O48S2; Miacalcin; Calcitonin salmon (synthesis); Calcitonine de saumon; Calcitonin, salmar; recombinant salmon calcitonin; Quosten; UNII-7SFC6U2VI5; Calcimar (TN); Steocin; Fortical; Caltine; Calsynar; Cadens; Calcitonin-salmon; Tonocalcin; Calcimar; Cibacalcine; Casalm; Calcinil; Catonin; Calcitonin vom lachs; Calcimonta; Riostin; Ostosalm; Osteovis; Calcihexal; Bionocalcin; Calcitoran; Salmofar; Calcioton; Calcitonin,salmon; Osseocalcina; Ucecal; Salmocalcin; C028815; Salcatonin; Astronin; Thyrocalcitonin (salmon); CALCITONIN, SALMON; Salcatyn; Salmon calcitonin; Calcitonin salmon (synthesis) (JAN); Salmon calcitonin I; Calcitonin [USAN:INN:BAN:JAN]; Citonina; Cibacalcin; 135506-95-5; Calcitonin, salmon, for bioassay; Sical; Calciben; Calsynar Lyo L; Forcaltonin
IndicationOsteoporosis
[ICD9: 733.0   ICD10: M80-M81]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C145H240N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-13
6(229)99-63-239-238-62-79(148)117(210)178-96(59-191)134(227)174-9
2(52-104(151)202)131(224)172-90(49-69(9)10)129(222)180-98(61-193)
135(228)187-114(74(16)197)142(235)181-99)118(211)158-55-106(204)1
62-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-
192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207
)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-
77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(21
9)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-
94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(2
30)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(
233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-5
6-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)
144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,1
10-115,190-199H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H
2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,2
11)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,
215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171
,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,17
7,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,1
83,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4
,154,155,157)
InChIKeyBBBFJLBPOGFECG-UHFFFAOYSA-N
Canonical SMILESCC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)
CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C
(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=
CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)
NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC
(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)
N5CCCC5C(=O)N)C(C)O)CO    
Therapeutic ClassAntiosteporotic Agents
CAS NumberCAS 47931-85-1
FormulaC145H240N44O48S2
PubChem Compound IDCID 16129616.
PubChem Substance IDSID 9082.
SuperDrug ATC IDH05BA01
H05BA01
TargetCalcitonin receptorBinder[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Peptides. 2009 Jul;30(7):1288-95. Epub 2009 Apr 7. To Reference
Ref 3Purification and characterization of calcitonin receptors in rat kidney membranes by covalent cross-linking techniques. Eur J Biochem. 1986 Feb 17;155(1):141-7. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543